Table of contents
- KEY TAKEAWAYS
- Quick Facts: PRP Therapy for Infertility in Pune
- PRP Fertility Research: Key Evidence 2024–2026
- What Is PRP and How Is It Prepared?
- Intra-Ovarian PRP: Who May Benefit?
- Intra-Uterine PRP: Thin Endometrium Treatment
- PRP Therapy Cost in Pune 2026
- Is PRP Covered Under Insurance or Ayushman Bharat?
- Frequently Asked Questions
KEY TAKEAWAYS
- PRP (Platelet-Rich Plasma) therapy uses growth factors from the patient’s own blood to stimulate tissue repair and regeneration.
- Intra-ovarian PRP is used for poor ovarian responders and premature ovarian insufficiency with promising early results.
- Intra-uterine PRP improves endometrial thickness in women with thin endometrium who have failed prior IVF transfers.
- PRP therapy cost in Pune ranges from INR 15,000 to INR 35,000 per session.
- Evidence is emerging and promising but PRP is still considered adjunct rather than first-line; discuss with your specialist.
- Dr. Bhagyashri Naphade at La Femme Fertility Clinic, Wakad, offers PRP as part of individualised fertility protocols.
PRP therapy for female infertility is one of the more exciting developments in reproductive medicine over the past decade. For women with poor ovarian response or recurrent implantation failure due to thin endometrium, it offers a potential additional tool when standard protocols have not worked.
This 2026 review by Dr. Bhagyashri Naphade at La Femme Fertility Clinic, Wakad, summarises the current clinical evidence and explains who in Pune might genuinely benefit from this treatment.
Quick Facts: PRP Therapy for Infertility in Pune
| Parameter | Details |
| PRP session cost in Pune | INR 15,000 to INR 35,000 per session |
| Number of sessions typically | 1 to 3 per treatment cycle |
| PRP for poor ovarian response | Improving AMH and follicle count in selected cases |
| PRP for thin endometrium | Improving lining thickness before FET |
| Evidence status | Emerging; adjunct therapy; not standalone first-line |
| Available at La Femme, Wakad | Yes |
PRP Fertility Research: Key Evidence 2024–2026
| Study Area | Finding | Source |
| Intra-ovarian PRP in poor responders | Improved AMH and AFC in select patients after treatment | PubMed-indexed studies 2022-2024 |
| PRP for thin endometrium (<7mm) | Endometrial thickness improved in 60 to 70 percent of cases | Industry research estimate |
| PRP and IVF outcomes | Improved clinical pregnancy rates in poor responder sub-groups | Published fertility journal data |
| Safety profile | No significant adverse events reported in published studies | Reproductive medicine literature |
| Limitations | Small sample sizes; lack of large RCTs; results variable | Academic consensus 2024 |
What Is PRP and How Is It Prepared?
Platelet-Rich Plasma is prepared by drawing approximately 20 to 30mL of the patient’s own blood and spinning it in a centrifuge to concentrate the platelets. Platelets contain growth factors including PDGF, VEGF, IGF and TGF-beta that stimulate cellular repair and tissue regeneration. The concentrated PRP is then injected into the target tissue.
Because PRP uses the patient’s own blood, there is no risk of rejection or allergic reaction. The procedure is relatively simple and takes 45 to 60 minutes in total including blood draw, centrifugation and injection.
Intra-Ovarian PRP: Who May Benefit?
Intra-ovarian PRP is most studied in women with poor ovarian reserve (low AMH, low AFC), premature ovarian insufficiency (POI) and poor responders in previous IVF cycles who retrieved fewer than 3 to 4 eggs despite standard stimulation. The hypothesis is that PRP growth factors stimulate dormant follicles and improve the ovarian microenvironment.
Early studies, including those published in PubMed-indexed reproductive medicine journals, show improvements in AMH levels and antral follicle counts in a proportion of treated women. However, results vary and not all patients respond. Your specialist will assess whether your case profile is likely to benefit before recommending the procedure.
Intra-Uterine PRP: Thin Endometrium Treatment
A uterine lining of at least 7mm is generally needed for embryo implantation. Women with chronic thin endometrium, often from previous uterine surgeries, infections or poor blood supply, who have failed prior FET cycles are candidates for intra-uterine PRP infusion. The PRP is introduced into the uterine cavity through a thin catheter, similar to an embryo transfer procedure.
Published data suggests endometrial thickness improved in 60 to 70 percent of cases treated with intra-uterine PRP, with subsequent improvement in implantation rates in some studies. Results are encouraging but further large-scale research is ongoing.
PRP Therapy Cost in Pune 2026
| PRP Application | Sessions Typically | Cost Per Session | Total Estimated Cost |
| Intra-ovarian PRP | 1 to 2 | INR 20,000 to INR 35,000 | INR 20,000 to INR 70,000 |
| Intra-uterine PRP | 1 to 3 | INR 15,000 to INR 25,000 | INR 15,000 to INR 75,000 |
| PRP + IVF cycle (combined) | Part of IVF protocol | As above | Adds to IVF cycle cost |
| Follow-up AMH or ultrasound | Per visit | INR 500 to INR 2,000 | 2 to 3 follow-up visits |
Is PRP Covered Under Insurance or Ayushman Bharat?
PRP therapy for fertility is not currently covered under Ayushman Bharat or most standard Indian health insurance policies. It is considered an experimental adjunct treatment and is usually an out-of-pocket expense. Discuss the potential benefit vs cost with your specialist before proceeding.
Conclusion
PRP therapy for female infertility in Pune represents a genuinely promising adjunct treatment for women with poor ovarian reserve and thin endometrium who have not responded adequately to standard protocols. The evidence is encouraging but still evolving, and the best results come when PRP is integrated thoughtfully into a comprehensive fertility plan.
If you are a poor responder or have had repeated implantation failures, book a consultation with Dr. Bhagyashri Naphade at La Femme Fertility Clinic, Wakad, to assess whether PRP therapy is right for your specific case.
Frequently Asked Questions
A: Yes, PRP uses the patient’s own blood, eliminating the risk of rejection or infection from foreign material. Published studies to date report no significant adverse events. As with any injection procedure, minor bruising or discomfort at the injection site can occur.
A: AMH levels and antral follicle count are typically reassessed 6 to 8 weeks after intra-ovarian PRP. If the response is positive, an IVF stimulation cycle is planned 1 to 2 months after treatment.
A: No. PRP is an adjunct treatment designed to improve the conditions for IVF. It does not replace ovarian stimulation, egg retrieval, fertilisation or embryo transfer. It is used alongside IVF for specific indications.
A: Yes. Dr. Bhagyashri Naphade offers PRP ovarian and uterine therapy as part of a tailored fertility protocol for selected patients. Book a consultation at lafemmeivf.in for evaluation.
A: PRP is not suitable for women with active blood disorders, platelet dysfunction, blood-borne infections (HIV, hepatitis) or those on anticoagulant medications. Your specialist will screen for contraindications before recommending the procedure.
Medical Disclaimer: This article is for informational purposes only and does not constitute professional medical advice. Always consult a qualified doctor before making healthcare decisions. Costs are indicative and may vary.
Dr. Bhagyashree Naphade
Dr. Bhagyashri Naphade is a highly trusted lady gynecologist and IVF specialist in Wakad, Pune, with an overall 20 years of practice and 10 years of experience as a gynecologist IVF specialist. Internationally trained in IVF from Germany and an ASRM award winner, she specializes in IVF, IUI, PCOD/PCOS, and women’s health.

